Table 3.
Subsequent Malignancies among Cancer Survivors.
| Author | No. Patients | Diagnosis | New Cancers |
|---|---|---|---|
| Ng & Travis 42 | 1,319 | Hodgkin's Disease | 189 (14.3%) |
| Hodgson, et al. 54 | 18,862 | Hodgkin 's disease | Men (18%) |
| Women (26%) | |||
| Metayer, et al. 55 | 5,925 | Hodgkin's Disease | 195 (3.2%) |
| Swerdlow, et al. 56 | 5,519 | Hodgkin's Disease | 322 (5.8%) |
| Okines 48 | 3,764 | Malignant Lymphoma | 68 (1.9%) |
| Heyne, et al. 59 | 47 | Small Cell Lung Cancer | 14 (30%) |
| van der Gaast, et al. 45 | 81 | Small Cell lung cancer | 5 (6.1%) |
| Takigawa, et al. 47 | 90 | Stage III Non-Small Cell Lung Cancer | 7 (7.8%) |
| 4/19 (21%) long-term Survivors | |||
| Raymond & Hogue 46 | 332,014 | Breast Cancer | 40,068 (12%) |
| Kirova, et al. 50 | 16,705 | Breast Cancer | 709 (4.2%) |
| Gianni, et al. 51 | 1,035 | Breast Cancer | 55 (5.3%) |
| Travis, et al. 43 | 40,576 | Testicular cancer | 2,285 (5.6%) |
| Stava, et al. 44 | 968 | Malignant Melanoma | 111 (11.4%) |
| Fernebro, et al. 49 | 818 | Soft Tissue Sarcoma | 113 (13.8%) |
| Chaturvedi, et al. 52 | 85,109 | Squamous Cell Ca. Cervix | 10,559 (12.4%) |
| 10,280 | Adenocarcinoma of Cervix | 920 (8.9%) |